Triple-negative breast cancer (TNBC) is characterized by the lack of expression of estrogen receptor α (ER-α), progesterone receptor (PR), and the absence of expression/amplification of human epidermal growth factor receptor 2 (HER2). The gene discussed is ESR1; the disease is triple-negative breast carcinoma.